Tilade 2mg / dose inhaler (Sanofi) 112 dose 2 x 56 doses

Type Pressurised aerosol inhaler (MDI)
Medicine Nedocromil 2mg/dose
Activation mechanism Non breath actuated
Dose counter No dose counter
Price £42.83 / 30 days
(based on 4 puffs / day)
  • Adult Asthma Licence
  • Adolescent Asthma Licence (age range not available)
  • Paediatric Asthma Licence (6 years and older)


There are 30 compatible spacers

Training material


Detailed prescribing information is provided below. This content has not been generated by the RightBreathe team, but has been integrated from a 3rd party solution: Multilex (provided by FirstDataBank). Use of this prescribing content is subject to the FirstDataBank disclaimer, which is set out in the "About" section of RightBreathe.

As RightBreathe is a bespoke decision support tool, it covers each and every individual known inhaler option on the UK market to a high level of specificity. Multilex, as a more general resource, does not offer the same level of specificity. There are therefore a small number of medicines for which there are discrepancies between RightBreathe and Multilex content, most notably in relation to licensed particulars and associated licensed doses.

Given the high level of specificity the RightBreathe team work to, details of the individual inhaler licence are most likely to be summarised accurately in the content provided at the top of this page, rather than in the Multilex content below. Where there is ambiguity, users may also wish to refer to individual summaries of product characteristics prior to prescribing.

Safety Advice Warnings

Adverse effects (report/action)

  • CSM (CHM) requests reporting of adverse reactions to cfc-free inhalers

Advice on Administration

  • Consider use of a spacer device for suitable patients and formulations

Advice on drug withdrawal

  • Do not withdraw this drug suddenly

Dose changes (other conditions)

  • Not licensed for use in children under 6 years
  • Use lowest dose at which effective control of asthma is maintained

Patient Counselling

  • Advise patient not to use for relief of acute attacks
  • Advise patient that CFC-free inhalers may have different taste or sensation
  • Advise patients that maximal therapeutic benefit will take several weeks
  • Ensure patient has a fast acting bronchodilator available
  • Patient should seek medical advice if usual relief is diminished
  • Use regularly to maintain freedom from symptoms

Recommended monitoring

  • Check patient is using correct inhaler technique

Safety/advice in other condition

  • Systemic corticosteroids may be needed during periods of stress


  • Breastfeeding
  • Pregnancy


  • Children under 5 years

Side Effects

  • Abdominal pain
  • Bronchospasm (paradoxical)
  • Chest tightness
  • Cough
  • Dysgeusia
  • Dyspepsia
  • Dyspnoea
  • Headache
  • Nausea
  • Pharyngitis
  • Throat irritation
  • Vomiting
  • Wheezing